Research News › Archive › Health & Medicine
New spin-off first to treat root cause of severe bleeding disorder
Health & Medicine · 27 May 2025
Hemastatx, a spin-off that emerges from research at KU Leuven Kulak, is working on a therapy for patients with a defect in von Willebrand factor: a severe bleeding disease with high clinical need.
Find the funding to take work like this further
Global Research Partnerships puts the world's major public funders in one search, and connects you with the collaborators who help you win. Free to search, always.
Search research funding →More research news
Harvard University
A clearer picture of drinking and disease
University of Wisconsin-Madison
UW–Madison researchers identify therapeutic target for dangerous fungal infections
University of Manchester
World-leading research receives cash boost in Manchester
EPFL Lausanne
EPFL launches the world's first fully open medical LLMs
University of Manchester
AI may unlock early disease clues hidden in routine eye exams
MIT